Evaluating Current Therapies for Idiopathic Pulmonary Fibrosis
0290-0000-18-149-H01-P
After attending this PTCE program, participants will be able to identify IPF treatment options for cost-effective disease management when selecting drug therapy.
1.50
Current and Emerging Treatment Standards for Patients with Chronic Lymphocytic Leukemia (CLL)
0290-0000-18-148-H01-P
This presentation by PTCE will provide information on current and emerging therapies for patients with CLL, how to incorporate these agents into specific treatment regimens, and more.
1.50
The Pharmacist's Role in Counseling Patients About Influenza Vaccinations
0290-0000-18-151-H01-P
This program presented by PTCE will help pharmacists become more aware of the associated costs and risks of not being vaccinated, how to address misconceptions surrounding the flu vaccine, and more
1.00
Preventing the Herpes Zoster Virus VIA Vaccination: The Role of the Retail Pharmacist as Patient Advocate, Identifier, Educator, and Immunizer
0290-0000-18-124-H01-P
With vaccination being the most effective method in preventing HZ, this article from PTCE will highlight knowledge for pharmacists regarding new updates to guidelines, and more.
2.00